SCHEMBL4861460

SCHEMBL4861460

CCCCCc1nc(C)c(C(=O)OCC)n1C

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.43
KMT2A Q03164 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
HCRTR1 O43613 1/20 0.39
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39
ALOX15 P16050 1/20 0.39
RAB9A P51151 1/20 0.39
USP2 O75604 1/20 0.37
TSHR P16473 1/20 0.36
AGTR1 P30556 1/20 0.35
AGTR2 P50052 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20138242 0.76 MAPK1 (0.50) MAPK1KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL370542 0.74 MAPK1 (0.49) MAPK1KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL9559956 0.73 MAPK1 (0.48) MAPK1KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL5807114 0.73 MAPK1 (0.44) MAPK1KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL11923732 0.71 KMT2A (0.43) MAPK1KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL4886946 0.71 AGTR1 (0.40) KMT2AKDM4EALDH1A1HPGDTP53
SCHEMBL22890640 0.70 SMN1; SMN2 (0.46) MAPK1KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL16851076 0.69 LMNA (0.49) MAPK1KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL16851069 0.69 LMNA (0.49) MAPK1KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL3228644 0.68 KMT2A (0.45) MAPK1KMT2ASMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008111794-A1 4-METHYLIMIDAZOL-5-YLCARBONYLGUANIDINE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF THE ISCHEMIC HEART DISEASES CONTAINING THE SAME AS AN ACTIVE INGREDIENT KOREA RESERACH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2008-09-18 WO disclosed